Categories
-
Adhesives
6
Amines
115
Amino Acids
210
Analytical Reagents
751
Antibiotics
275
Bioactive Small Molecules
806
Aroma Chemicals
247
Biochemicals
1158
Boronic Acids
4
Buffers
105
Building Blocks
2196
Carbohydrates
193
Catalysts
120
Chiral Compounds
77
Coccus nucifera oil
0
Detergents
63
Diagnostic Raw Materials
273
Flavours and Fragrance Materials
236
Fluorinated Products
68
Furans
7
Gases in Solution
53
Grignard Reagents
32
HPLC Reagents
8
Imidazoles
19
Indoles
48
Inorganic Chemicals
360
Ion-Pair Reagents
21
Ligands
81
Organics
1651
Oxazoles
3
Peptide Reagents
102
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
69
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
895
Salts
311
Sealing Compounds
1
Sherclin
1
Solvents
134
Stains & Indicators
324
Sugars
67
Tailor-made solutions
1
Testing Standards
4
Uncategorised
23
Water Analysis
12
Doripenem
(14558613 | 148016-81-3)
| CAS: | 148016-81-3 |
|---|---|
| Molecular Formula: | C15H24N4O6S2 |
| Molecular Weight: | 420.51 |
| Availablility: | Inquire for Status |
|---|---|
| Downloads: | Product Specification |
| 14558613-100mg | 100mg | £62.30 | |
| Bulk Order | |||
| 14558613-100mg | 100mg | €87.30 | |
| Bulk Order | |||
| 14558613-100mg | 100mg | $93.50 | |
| Bulk Order | |||
Specification
Certificate of Analysis
Product Detail
| Product Code | 14558613 | ||||
| Product Name | Doripenem | ||||
| Categories | Antibiotics Biochemicals Research Organics & Inorganics | ||||
| CAS | 148016-81-3 | ||||
| Molecular Formula | C15H24N4O6S2 | ||||
| Molecular Weight | 420.51 | ||||
| Storage Details | 2 to 8 °C | ||||
| Harmonised Tariff Code | 29419000 EXP 2941900000 IMP |
Product Specification
| Physical Appearance | Off-white to light yellow powder | ||||
| Loss on Drying | 4.5% -6.5% | ||||
| Assay | >98% | ||||
| Optical Rotation | +32° to +38° | ||||
| Sulfated ash | <0.1% | ||||
| Identification 1H-NMR | Conforms to standard |
Safety Information
| Pictograms |
|
||||
| Signal word | none | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|